Osteonecrosis in children and adolescents with cancer

Pediatric Blood and Cancer

Volumn 50, Issue 2 SUPPL., 2008, Pages 483-485

  Barr, Ronald D ^a   Sala, Alessandra ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Adolescent; Child; Neoplasms; Osteonecrosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; STEROID;

AGE; BONE NECROSIS; CHILDHOOD CANCER; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; ELECTROSTIMULATION; GENDER; GENETIC PREDISPOSITION; HUMAN; HYPERBARIC OXYGEN; LYMPHATIC LEUKEMIA; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC SURGERY; OSTEOPENIA; PATHOGENESIS; PERTHES DISEASE; PHARMACOGENETICS; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY;

ADOLESCENT; CHILD; HUMANS; NEOPLASMS; OSTEONECROSIS; PHARMACOGENETICS; RISK FACTORS; SEX CHARACTERISTICS;

EID: 37549072266     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21405     Document Type: Short Survey

References (49)

1. Ribeiro RC, Fletcher BD, Kennedy W, et al. Magnetic resonance imaging detection of avascular necrosis of bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia 2001;15:891-897.
2. Hanada T, Horigome Y, Inudoh M, et al. Osteonecrosis of vertebrae in a child with acute lymphocytic leukemia during L-asparaginase therapy. Eur J Pediatr 1989;149:162-163.
3. Kardos G, Ronde FMY, Bourier M, et al. Avascular necrosis of bone in children with acute lymphoblastic leukemia. Med Pediatr Oncol 1995;25:286(abstr P-30).
4. Ishii E, Yoshida N, Miyazaki S. Avascular necrosis of bone in neuroblastoma treated with combination chemotherapy. Eur J Pediatr 1984;143:152-153.
5. Nixon JE. Avascular necrosis of bone: A review. J Roy Soc Med 1983;76:681-692.
6. Mankin HJ. Non-traumatic necrosis of bone (osteonecrosis). N Engl J Med 1992;326:1473-1479.
7. Assouline-Dayan Y, Chang C, Greenspan A, et al. Pathogenesis and natural history of osteonecrosis. Sem Arthritis Rheum 2002;32:94-124.
8. Kenzora JE. Ischemic necrosis of the femoral head. Part 1. Accumulative cell stress: A hypothesis for the etiology of idiopathic osteonecrosis. Instr Course Lect 1983;32:242-252.
9. Motomura G, Yamamoto T, Miyanishi K, et al. Bone marrow fat-cell enlargement in early steroid-induced osteonecrosis: A histomorphometic study of autopsy cases. Pathol Res Pract 2005;200:807-811.
10. Collaborative Osteonecrosis Group. Symptomatic multifocal osteonecrosis. A multi center study. Clin Orthop Relat Res 1999;369:312-326.
11. Chollet CT, Britton L, Neel MD, et al. Childhood cancer survivors: An at-risk cohort for ankle osteonecrosis. Clin Orthop Relat Res 2005;430:149-155.
12. Mattano LA, Sather HV, Trigg ME, et al. Osteonecrosis as a complication of treating actue lymphoblastic leukemia in children: A report from the Children's Cancer Group. J Clin Oncol 2000;18:3262-3272.
13. Cheng EY, Thongtrangan I, Laorr A, et al. Spontaneous resolution of osteonecrosis of the femoral head. J Bone Joint Surg 2004;86A:2594-2599.
14. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: Treatment by mold arthorplasty. An end result study using a new method of result evaluation. J Bone Joint Surg 1969;51A:737-755.
15. Marcus ND, Enneking WF, Massam R. The silent hip in idiopathic aseptic necrosis. J Bone Joint Surg 1973;55A:1351-1366.
16. Koshino T. The treatment of spontaneous osteonecrosis of the knee by high tibial osteotomy with and without bone grafting or drilling of the lesion. J Bone Joint Surg 1982;64A:47-58.
17. Ficat RP. Idiopathic bone necrosis of the femoral head. J Bone Joint Surg 1985;67B:3-9.
18. Ohzono K, Saito M, Takaoka K, et al. Natural history of non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg 1991;73B:68-72.
19. ARCO. Committee on Terminology and Staging. ARCO Newslett 1992;4:41-46.
20. Shimizu K, Moriya K, Akita T, et al. Prediction of relapse with magnetic resonance imaging of avascular necrosis of the femoral head. J Bone Joint Surg 1994;76A:215-223.
21. Steinberg ME, Hayken GD, Steinberg DR. A quantitative system for staging avascular necrosis. J Bone Joint Surg 1995;77:34-41.
22. Saini A, Saifuddin A. MRI of osteonecrosis. Clin Radiol 2004;59:1079-1093.
23. Karimova EJ, Rai SR, Deng X, et al. MRI of knee osteonecrosis in children with leukemia and lymphoma. Part 1. Observer agreement. Am J Radiol 2006;186:470-476.
24. Karimova EJ, Rai SR, Ingle D, et al. MRI of knee osteonecrosis in children with leukemia and lymphoma. Part 2. Clinical and imaging patterns. Am J Radiol 2006;186:477-482.
25. Strauss AJ, Su JT, Kimball Dalton VM, et al. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 2001;19:3066-3072.
26. Arico M, Boccalatte MFP, Silvestri D, et al. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 2003;88:747-783.
27. Hogler W, Wehl G, van Staa T, et al. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: Comparison of fracture risk with the General Practice Research Database. Pediatr Blood Cancer 2007;48:21-27.
28. Burger B, Beier R, Zimmermann M, et al. Osteonecrosis: A treatment-related toxicity in childhood acute lymphoblastic leukemia (ALL) - Experiences from trial ALL-BFM 95. Pediatr Blood Cancer 2005;44:220-225.
29. Lackner H, Benesch M, Moser A, et al. Aseptic osteonecrosis in children and adolescents treated for hemato-oncologic diseases: A 13 year longitudinal observational study. J Pediatr Hematol Oncol 2005;27:259-263.
30. Relling MV, Yang W, Das S, et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 2004;19:3920-3936.
31. Liu YF, Chen WM, Lin YF, et al. Type II collagen gene variants and inherited osteonecrosis of the femoral head. N Engl J Med 2005;352:2294-2301.
32. Celik A, Tekis D, Saglam F, et al. Association of corticosteroids and factor V, prothrombin and MTHFR gene mutations with avascular osteonecrosis in renal allograft recipients. Transpl Proc 2006;38:512-516.
33. Bernbeck B, Manz-Korholz C, Zotz RB, et al. Methylenetetrahy-drofolate reductase gene polymorphism and glucocorticoid intake in children with ALL and aseptic osteonecrosis. Klin Padiatr 2003;215:327-331.
34. Hungerford DS, Jones LC. Asymptomatic osteonecrosis: Should it be treated? Clin Orthop Relat Res 2004;429:124-130.
35. Israelite C, Nelson CL, Ziarani CF, et al. Bilateral core decompression for osteonecrosis of the femoral head. Clin Orthop Relat Res 2005;441:285-290.
36. Wei SY, Esmail AN, Bunin N, et al. Avascular necrosis in children with acute lymphoblastic leukemia. J Pediatr Orthop 2000;20:331-335.
37. Yen CY, Tu YK, Ma CH, et al. Osteonecrosis of the femoral head: Comparison of clinical results for vascularised iliac and fibula bone grafting. J Reconstr Microsurg 2006;22:21-24.
38. Lieberman JR, Conduah A, Urist MR. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res 2004;429:139-145.
39. Trancik T, Lunceford E, Strum D. The effect of electrical stimulation on osteonecrosis of the femoral head. Clin Orthop Relat Res 1990;256:120-124.
40. Steinberg ME, Brighton T, Bands RE, et al. Capacitance coupling as an adjunctive treatment for avascular necrosis. Clin Orthop Relat Res 1990;261:11-18.
41. Bernbeck B, Christaras A, Krauth K, et al. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukemia or non-Hodgkin lymphoma treated with hyperbaric-oxygen-therapy (HBO): An approach to cure? - BME/AON and hyperbaric oxygen therapy as a treatment modality. Klin Padiatr 2004;216:370-378.
42. Agarwala S, Jain D, Joshi VR, et al. Efficacy of Alendronate, a bisphosphonate, in the treatment of avn of the hip. A prospective open-label study. Rheumatology 2005;44:352-359.
43. Nishii T, Sugano N, Miki H, et al. Does alendronate prevent collapse in osteonecrosis of the femoral head? Clin Orthop Relat Res 2006;443:273-279.
44. Lai KA, Shen WJ, Yang CY, et al. The use of alendronate to prevent early collapse of the femoral head in patients with non-traumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg 2005;87A:2155-2159.
45. Aspenberg P. Pharmacological treatment of osteonecrosis. Acta Orthop 2006;77:175-176.
46. Woo S-B, Hellstein JW, Kalmar JR. Systematic review: Bisphosphonates and osteonecrosis of the jaws. Ann Int Med 2006;144:753-761.
47. Wiernikowski JT, Barr RD, Webber C, et al. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma. J Oncol Pharmacy Pract 2005;11:51-56.
48. Atkinson SA, Halton J, Bradley C, et al. Mineral and bone abnormalities in childhood acute lymphoblastic leukemia: Influence of disease, drugs and nutrition. Int J Cancer 1998; Suppl 11:35-39.
49. Sala A, Talsma D, Webber C, et al. Bone mineral status after treatment of malignant lymphoma in childhood and adolescence. Eur J Cancer Care 2007;16:373-379.